Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.

Di Bisceglie AM, Stoddard AM, Dienstag JL, Shiffman ML, Seeff LB, Bonkovsky HL, Morishima C, Wright EC, Snow KK, Lee WM, Fontana RJ, Morgan TR, Ghany MG; HALT-C Trial Group.

Hepatology. 2011 Apr;53(4):1100-8. doi: 10.1002/hep.24169.

PMID:
21480316
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection.

Hoare M, Gelson WT, Das A, Fletcher JM, Davies SE, Curran MD, Vowler SL, Maini MK, Akbar AN, Alexander GJ.

J Hepatol. 2010 Aug;53(2):252-60. doi: 10.1016/j.jhep.2010.03.005. Epub 2010 Apr 22.

PMID:
20462651
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial.

Delgado-Borrego A, Jordan SH, Negre B, Healey D, Lin W, Kamegaya Y, Christofi M, Ludwig DA, Lok AS, Chung RT; Halt-C Trial Group.

Clin Gastroenterol Hepatol. 2010 May;8(5):458-62. doi: 10.1016/j.cgh.2010.01.022. Epub 2010 Feb 12.

PMID:
20156586
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.

Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE, Ghany MG, Mills AS, Nash SR, Govindarajan S, Rogers TE, Greenson JK, Brunt EM, Bonkovsky HL, Morishima C, Litman HJ; HALT-C Trial Group.

Hepatology. 2010 Feb;51(2):585-94. doi: 10.1002/hep.23315.

PMID:
20101752
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study.

Farzaneh-Far R, Lin J, Epel E, Lapham K, Blackburn E, Whooley MA.

PLoS One. 2010 Jan 8;5(1):e8612. doi: 10.1371/journal.pone.0008612.

PMID:
20072607
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The emerging role of telomere biology in cardiovascular disease.

Huzen J, de Boer RA, van Veldhuisen DJ, van Gilst WH, van der Harst P.

Front Biosci (Landmark Ed). 2010 Jan 1;15:35-45. Review.

PMID:
20036804
[PubMed - indexed for MEDLINE]
7.

Homeostatic proliferation and survival of naïve and memory T cells.

Boyman O, Létourneau S, Krieg C, Sprent J.

Eur J Immunol. 2009 Aug;39(8):2088-94. doi: 10.1002/eji.200939444. Review.

PMID:
19637200
[PubMed - indexed for MEDLINE]
8.

Weight loss in obese men is associated with increased telomere length and decreased abasic sites in rectal mucosa.

O'Callaghan NJ, Clifton PM, Noakes M, Fenech M.

Rejuvenation Res. 2009 Jun;12(3):169-76. doi: 10.1089/rej.2008.0819.

PMID:
19594325
[PubMed - indexed for MEDLINE]
9.

Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG; HALT-C Trial Group.

Gastroenterology. 2009 Aug;137(2):549-57. doi: 10.1053/j.gastro.2009.05.007. Epub 2009 May 13.

PMID:
19445938
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Association of shorter mean telomere length with risk of incident myocardial infarction: a prospective, nested case-control approach.

Zee RY, Michaud SE, Germer S, Ridker PM.

Clin Chim Acta. 2009 May;403(1-2):139-41. doi: 10.1016/j.cca.2009.02.004. Epub 2009 Feb 13.

PMID:
19217888
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL; HALT-C Trial Investigators.

N Engl J Med. 2008 Dec 4;359(23):2429-41. doi: 10.1056/NEJMoa0707615.

PMID:
19052125
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Nutrient sensing and inflammation in metabolic diseases.

Hotamisligil GS, Erbay E.

Nat Rev Immunol. 2008 Dec;8(12):923-34. doi: 10.1038/nri2449. Review.

PMID:
19029988
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD; HALT-C Trial Group.

Gastroenterology. 2009 Jan;136(1):138-48. doi: 10.1053/j.gastro.2008.09.014. Epub 2008 Sep 18.

PMID:
18848939
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Interferon-beta1b for the treatment of multiple sclerosis.

Lam S, Wang S, Gottesman M.

Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1111-7. doi: 10.1517/17425255.4.8.1111 . Review.

PMID:
18680445
[PubMed - indexed for MEDLINE]
15.

Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people.

Koch S, Larbi A, Derhovanessian E, Ozcelik D, Naumova E, Pawelec G.

Immun Ageing. 2008 Jul 25;5:6. doi: 10.1186/1742-4933-5-6.

PMID:
18657274
[PubMed]
Free PMC Article
16.

Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span.

Dixit VD.

J Leukoc Biol. 2008 Oct;84(4):882-92. doi: 10.1189/jlb.0108028. Epub 2008 Jun 25. Review.

PMID:
18579754
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.

Antonini MG, Babudieri S, Maida I, Baiguera C, Zanini B, Fenu L, Dettori G, Manno D, Mura MS, Carosi G, Puoti M.

Infection. 2008 Jun;36(3):250-5. doi: 10.1007/s15010-007-7132-6. Epub 2008 May 3.

PMID:
18458815
[PubMed - indexed for MEDLINE]
18.

Telomere length and obesity.

Zannolli R, Mohn A, Buoni S, Pietrobelli A, Messina M, Chiarelli F, Miracco C.

Acta Paediatr. 2008 Jul;97(7):952-4. doi: 10.1111/j.1651-2227.2008.00783.x.

PMID:
18430074
[PubMed - indexed for MEDLINE]
19.

Telomeres and aging.

Aubert G, Lansdorp PM.

Physiol Rev. 2008 Apr;88(2):557-79. doi: 10.1152/physrev.00026.2007. Review.

PMID:
18391173
[PubMed - indexed for MEDLINE]
Free Article
20.

Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion.

Hauschild A, Gogas H, Tarhini A, Middleton MR, Testori A, Dréno B, Kirkwood JM.

Cancer. 2008 Mar 1;112(5):982-94. doi: 10.1002/cncr.23251. Review.

PMID:
18236459
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk